secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001140361-25-017983
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys Q1 sales up 25.9% but net loss widens to $5.9M; cash runway only into early Q3 2025
--------------------------------------------------------------------------------

- Sales increased 25.9% YoY to $341K, driven by FemaSeed sales.
- Net loss widened to $5.9M ($0.23 per share) from $3.6M ($0.17) in prior year.
- R&D expenses surged 67.6% to $2.97M, mainly due to regulatory and development costs.
- Cash and equivalents $3.8M; company expects to fund operations only into early Q3 2025.
- FemBloc delivery system received CE mark recommendation in Europe; FemaSeed partnerships expanded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125017983/0001140361-25-017983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036125017983/ef20048606_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-017983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer